Folding-Mediated DNA Delivery by α-Helical Amphipathic Peptides.

James E Noble, Paula Vila-Gómez, Stephanie Rey, Camilla Dondi, Andrea Briones, Purnank Aggarwal, Alex Hoose, Maryana Baran, Maxim G Ryadnov

Journal: ACS biomaterials science & engineering 2023;9(5):2584-2595

PMID: 37014978

Abstract

The renaissance gene therapy experiences these days requires specialist biomaterials and a systemic understanding of major factors influencing their ability to deliver genetic material. Peptide transfection systems represent a major class of such biomaterials. Several peptidic reagents have been commercialized to date. However, a comparative assessment of peptide sequences alone without auxiliary support or excipients against a common determinant for their ability to complex and deliver DNA has been lacking. This study cross-compares commercial and experimental transfection reagents from the same family of helical amphiphiles. Factors defining the efficacy of DNA delivery including cell uptake and gene expression are assessed along with cytotoxicity and DNA complexation. The results show that despite differences in sequence composition, length, and origin, peptide reagents of the same structural family exhibit similar characteristics and limitations with common variability trends. The cross-comparison revealed that functional DNA delivery is independent of the peptide sequence used but is mediated by the ability of the reagents to co-fold with DNA. Peptide folding proved to be the common determinant for DNA complexation and delivery by peptidic transfection reagents.

Address: National Physical Laboratory, Hampton Road, Teddington TW11 0LW, U.K.; Department of Brain Sciences, Imperial College London, London W12 0TR, U.K.; Department of Physics, King's College London, London WC2R 2LS, U.K.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.